Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib in Frontal Fibrosing Alopecia
NCT06240351Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2024
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of baricitinib in frontal fibrosing alopecia (FFA), sponsored by University of Alabama at Birmingham. Started Apr 2024; status: completed.
02
Drugs
baricitinib
03
Conditions
frontal fibrosing alopecia (FFA)
Beyond the preview
Go deeper on NCT06240351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06240351.